文献速递儿童青少年精神

自闭症及相关疾病的人类细胞模型

Human Cellular Models of Autism and Related Conditions.
PubMed 文献 · Biol Psychiatry · 2026-07-10

本文综述人类胚胎干细胞和诱导多能干细胞模型在自闭症谱系障碍(ASD)研究中的应用。模型从单基因研究进展到多基因并行研究,揭示神经发生失调、细胞类型特化异常和突触活动紊乱等汇聚性致病机制,并用于评估FDA批准药物对早期神经发育的影响。

要点

  • 人细胞模型可揭示ASD早期发育病理生理机制,并将体外表型与供者临床特征关联。
  • ASD模型中发现神经发生失调、谷氨酸能神经元缺陷和GABA能神经元扩增等汇聚表型。
  • hiPSC模型用于评估mTOR抑制剂等FDA批准药物对早期人神经发育的影响。

核心结论

  • 人类细胞模型能揭示ASD早期发育病理生理,并关联体外表型与供者临床特征。
  • ASD细胞模型鉴定出多个汇聚性致病机制和分子原则,如染色质、WNT和mTOR信号失调。

研究设计与样本

  • 综述人类胚胎干细胞和人诱导多能干细胞(hiPSC)来源的ASD细胞模型研究。

主要发现

  • hiPSC模型从研究单基因进展到多路并行方法,可同时研究多个ASD风险基因。
  • ASD细胞模型发现神经发生失调、细胞类型特化异常和突触活动紊乱。
  • 细胞类型特化异常包括谷氨酸能神经元缺陷和GABA能神经元扩增。
  • 常见分子原则包括染色质、WNT信号和mTOR信号失调。
  • hiPSC模型用于评估FDA批准化合物(如mTOR抑制剂)对早期人神经发育的影响。

临床怎么用

  • 人细胞模型可用于研究ASD早期发育病理生理和评估治疗化合物对神经发育的影响。
  • 部分mTOR抑制剂正在ASD相关疾病的临床试验中。

局限性

  • 人类细胞模型存在局限性,但具体局限未在摘要中详述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human cellular models are enabling the in vitro study of the complex molecular and cellular mechanisms underlying autism spectrum disorder (ASD). Human embryonic stem cell- and human induced pluripotent stem cell (hiPSC)-derived models have progressed from investigating single genes to multiplexed approaches that have allowed the study of several ASD risk genes in parallel, which have expanded our understanding of how coding and noncoding genetic variants shape cellular and molecular phenotypes in ASD. Additionally, these models have identified several convergent pathogenic mechanisms in ASD, including dysregulated neurogenesis, altered cell-type specification (such as defects in glutamatergic neurons and expansion of GABAergic [gamma-aminobutyric acidergic] neurons), and disrupted synaptic activity. Common molecular principles are also emerging, including dysregulation of chromatin, WNT signaling, and mTOR (mechanistic target of rapamycin) signaling. hiPSC models of ASD have also been used to evaluate the effect of several U.S. Food and Drug Administration-approved therapeutic compounds on early human neural development, such as mTOR inhibitors, some of which are currently in clinical trials for ASD-related conditions. Although human cellular models have limitations, their unique strength is the ability to reveal early developmental pathophysiology and the potential to correlate in vitro phenotypes with the clinical features of patient donors. Here, we examine how human cellular models have advanced basic and translational research in ASD and identify key cellular and molecular convergent phenotypes that have emerged.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Guttikonda SR, Makinson CD. Human Cellular Models of Autism and Related Conditions. Biol Psychiatry. 2026. PMID: 42431437. doi:10.1016/j.biopsych.2026.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。